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CASE REPORTS 
Percutaneous Excimer Laser Angioplasty of Aortocoronary Saphenous 
Vein Grafts 
FRANK LTTVACK, MD, FACC, WARREN S. GRUNDFEST, MD, TSVI GOLDENBERG, PHD, 
JAMES LAUDENSLAGER, PHD, JAMES S. FORRESTER, MD, FACC 
Los Anyeles, Ca[ijornia 
Percutaneous coronary excimer laser angioplasty was suc- 
cessfully performed in two patients. An 85 year old woman 
with a 99% stenosis in a vein graft to a posterior descending 
artery had the stenosis reduced to 30% with laser angio- 
plasty. Subsequent balloon angioplasty reduced the stenosis 
further to 20%. A second patient, a man aged 50 years, had 
multiple previous balloon angioplasties and stent implanta- 
tion with two subsequent percutaneous atherectomies. La- 
ser angioplasty of the vein graft to the obtuse marginal 
branch reduced the first of three sequential lesions from 
60% to 40%. the second lesion from 90% to none and the 
The use of laser energy applied through flexible fiber-optic 
catheters has the potential to serve as an adjunct or alterna- 
tive to conventional balloon angioplasty. A variety of dif- 
ferent laser sources and catheter designs have been 
applied first to peripheral arteries and, more recently. to 
the coronary circulation. The earliest trials were conducted 
with continuous wave argon ion or neodymium:yttrium 
aluminum garnet (Nd:YAG) laser sources (l-3). These lasers 
ablate tissue primarily by thermal mechanisms (4). The 
ultraviolet excimer lasers ablate material through a 
different process from that used by the continuous wave 
lasers. Although exact mechanisms of ablation by excimer 
lasers remain to be elucidated, the relatively high energy 
ultraviolet photons may remove tissue by the process of 
ablative photodecomposition (5). The bonds holding the 
molecules may be directly disrupted, causing tissue re- 
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third from 60% to 20% without the need for balloon 
angioplasty. Both procedures were well tolerated without 
chest pain, burning, vascular perforation or thromhus 
formation. 
These cases demonstrate the feasibility of safely per- 
forming percutaneous coronary excimer laser angioplasty. 
Additional studies are indicated to determine the clinical 
role and potential benelits of this procedure in relation to 
established procedures and other experimental devices. 
(J Am Co11 Cardiol1989;14:803-S) 
moval by breakdown into constituent molecules. Regard- 
less of mechanism, excimer lasers possess some unique 
characteristics. They cut with extreme precision, generate 
little local heat and ablate even densely calcified tissues 
(6). 
Because of the attenuation of ultraviolet energy through 
fiber optics and the high peak power of the nanosecond 
pulses. the ability to transmit high energy excimer light 
through fiber optics has presented significant engineering 
obstacles (7). With the use of 308 nm and by prolonging the 
excimer pulse to >85 ns, excimer transmission through 
fibers has become possible (8). 
This technology has recently been applied successfully as 
an aid to revascularization in patients with peripheral vas- 
cular disease. In 30 patients with 22 occlusions and 9 
stenoses of their femoropopliteal arteries, an initial success 
rate of 77% was reported (9). Recently, a trial evaluating 
percutaneous excimer laser angioplasty for the coronary 
circulation was initiated after approval by the Food and Drug 
Administration and the Cedars-Sinai Human Studies Com- 
mittee. The purpose of this report is to describe the first two 
patients who have undergone percutaneous excimer laser 
angioplasty applied to aortocoronary saphenous vein grafts. 
To our knowledge, this represents the first application of this 
technology applied percutaneously to the coronary circula- 
tion. 
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LUYLN FOR A 
0.010’ GUIDE WIRE 
Figure 1. Schematic of SF catheter used for percutaneous excimer 
angioplasty in saphenous vein grafts. Twelve individual 200 pm 
substantially pure silica fibers are concentrically arranged around a 
guide wire lumen. 
Case 1 
Case Reports 
Clinical history. An 85 year old white woman was re- 
ferred for treatment of a stenosis in a saphenous vein graft to 
a native posterior descending artery. She had known triple 
vessel disease of the native coronary arteries and in I986 
underwent coronary artery bypass grafting with grafts to the 
left anterior descending, left circumflex and right coronary 
arteries. In January 1987 she presented with recurrent angina 
and occlusion of three vein grafts. She underwent repeat 
coronary artery bypass surgery with placement of an internal 
mammary graft to the left anterior descending artery and 
vein grafts to the posterior descending, left circumflex and 
diagonal arteries. In October 1987 she presented with recur- 
rent angina and a subtotal stenosis in the distal saphenous 
vein graft to the posterior descending artery. Successful 
balloon angioplasty was performed. In February 1988 she 
again presented with severe angina and restenosis of the 
previously dilated saphenous vein graft. A second balloon 
angioplasty was initially successful. In June 1988 she pre- 
sented with clinical and angiographic restenosis of the pre- 
viously dilated vein graft; a third angioplasty was immedi- 
ately successful. She was treated with diltiazem (30 mg four 
times daily), aspirin (325 mg once daily), digoxin (0.25 mg 
once daily) and coumadin (1 mg once daily). 
On August 19, 1988 she had an episode of sudden cardiac 
arrest with documented ventricular fibrillation and was re- 
suscitated by paramedical workers. On hospital admission, 
an acute myocardial infarction was ruled out. Aspiration 
pneumonia was successfully treated and she had complete 
neurologic recovery. Angiography again revealed severe 
triple vessel disease of the native coronary arteries (un- 
changed from the previous study) and patency of the internal 
mammary artery graft and grafts to the left circumflex and 
diagonal branches. The graft to the posterior descending 
artery had a 99% stenosis at the site of previous dilations. On 
August 26, 1988, after informed consent was obtained under 
a protocol approved by the Institutional Review Board of 
Cedars-Sinai Medical Center and the United States Food 
and Drug Administration, the patient underwent percutane- 
ous excimer laser angioplasty of the stenotic saphenous vein 
graft to the posterior descending artery. 
Excimer laser angioplasty of saphenous vein graft. The 
laser was a 308 nm, xenon-chloride excimer device designed 
and constructed by the laser physics group at the National 
Aeronautics and Space Administration-Jet Propulsion Lab- 
oratories. The laser emits up to 150 mJ/pulse with an 85 ns 
duration at 20 Hz. The electronic characteristics of this 
device have been previously described (10). The laser cath- 
eter (Advanced Interventional Systems, Inc.) is 5F and 
consists of 12 individual 200 pm substantially pure silica 
fibers concentrically arranged around a lumen for up to a 
0.018 in. (0.05 cm) guide wire (Fig. 1). It was calibrated to 
emit 308 nm energy at 35 mJ/mm* per pulse. 
The patient was prepared for the procedure, which was 
performed with use of standard angioplasty technique by 
way of percutaneous femoral approach. An 8F introducer 
sheath was placed into the right femoral artery and 10,000 U 
of heparin administered intravenously. Baseline cineangio- 
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Figure 2. Case 1. A, Baseline angiogram dem- 
onstrates subtotal stenosis in the saphenous 
vein graft to the posterior descending artery. B, 
Before excimer angioplasty. the 0.018 in. (0.05 
cm) guide wire is across the lesion and the SF 
excimer catheter is just proximal to the steno- 
sis. C, After excimer angioplasty with 525 
pulses at 35 millijoules/mm2, a residual stenosis 
of 30% is present. D, After balloon angioplasty 
with both 3.0 mm and 3.5 mm diameter bal- 
loons, only marginal improvement has been 
obtained as compared with laser alone (C). 
grams demonstrated the previously visualized 99% stenosis 
in the distal third of the saphenous vein graft (Fig. 2A). An 
8F multipurpose guiding catheter (Interventional Medical 
Inc.) was used to intubate the ostium of the vein graft. The 
laser catheter, loaded with a 0.018 in. (0.05 cm) guide wire 
(Advanced Cardiovascular Systems, Inc.) was advanced to 
the origin of the graft. The wire was placed down the vein 
graft and across the stenotic lesion into the native posterior 
descending artery. The laser catheter was advanced over the 
guide wire and positioned at the origin of the stenotic lesion 
(Fig. 2H). Under fluoroscopic control and with the laser 
firing, the catheter was slowly advanced across the lesion. 
This was achieved without resistance. The catheter was 
withdrawn proximal to the lesion and the process repeated a 
second time. A total of 525 excimer pulses were delivered to 
the lesion. The laser catheter was withdrawn. Repeat angi- 
ography revealed a residual stenosis of 30% (Fig. 2C). 
In an attempt to further reduce the stenosis, conventional 
balloon angioplasty was performed to the lesion first with a 
3.0 mm and then with a 3.5 mm diameter conventional 
balloon catheter (Advanced Cardiovascular Systems, Inc.). 
After completion of balloon dilation, the catheters and guide 
wire were withdrawn and final angiograms were obtained. 
Balloon angioplasty resulted in only marginal improvement 
over that achieved with excimer angioplasty alone (Fig. 2D). 
The sheaths were secured and the patient was transferred to 
the cardiac intensive care unit where she was treated with 
intravenous heparin for 24 h. She had an uneventful hospital 
course and. before discharge, underwent an electrophysio- 
logic study in which monomorphic sustained ventricular 
tachycardia could not be induced. 
Follow-up. After discharge, the patient was maintained 
on aspirin and diltiazem therapy. She had no angina or other 
cardiac symptoms. At 4 weeks she required evacuation of a 
subdural hematoma thought to be caused by head trauma 
incurred at the time of cardiac arrest. At 8 month follow-up 
she was well, angina free and pursuing an active life. She has 
refused follow-up angiography or stress testing. 
Cast? 2 
Clinical history. A 55 year old man was referred for laser 
angioplasty. He had undergone coronary artery bypass 
grafting in 1977. In 1983 he presented with recurrent angina 
and underwent a second bypass operation. He had a left 
internal mammary artery graft placed to the left anterior 
descending artery, a right internal mammary artery graft to 
the posterior descending artery, a vein graft to the diagonal 
branch and another vein graft to a circumflex obtuse mar- 
ginal branch. He did well until October 1986. when he 
presented with recurrent angina. Angiography revealed pa- 
tency of both internal mammary grafts with diffuse noncrit- 
ical disease in the vein graft to the diagonal branch and a 
significant lesion in the midportion of the vein graft to the 
806 LITVACK ET AL. 
EXCIMER LASER ANGIOPLASTY OF VEIN GRAFTS 
JACC Vol. 14, No. 3 
September lYLW803-8 
Figure 3. Case 2. A, Baseline angio- 
gram of graft to obtuse marginal branch 
demonstrates 60% stenosis at the ori- 
gin of a previously implanted endovas- 
cular stent (upper arrow) and 90% ste- 
nosis at lower margin of stent (middle 
arrow) as well as 60% stenosis in the 
distal graft (lower arrow). B, After laser 
angioilasty with 1,956 excimer pulses 
at 35 milliioules/mm2. a 40% stenosis 
remains a; the proximal portion of the 
stent (upper arrow), no visible stenosis 
is seen at the second lesion (middle 
arrow) and a 20% stenosis remains at 
the third lesion (lower arrow). 
obtuse marginal branch. He underwent angiographically 
successful balloon angioplasty at that time. In early Novem- 
ber 1986 he presented with recurrent angina and angio- 
graphic restenosis at the dilated site in the obtuse marginal 
graft. A second initially successful balloon angioplasty was 
performed. In late November 1986 he again developed 
angina with angiographic restenosis at the dilated site. A 
third initially successful balloon angioplasty was performed 
at that time. Two months later, in January 1987, he devel- 
oped recurrent symptoms with angiographic restenosis in the 
obtuse marginal graft. A fourth balloon angioplasty was 
initially successful and had a good short-term result. 
In April 1987 the patient’s angina1 symptoms recurred and 
angiography revealed restenosis and progression of diffuse 
disease in the graft to the diagonal branch. Despite maximal 
medical therapy, disabling angina persisted. A third bypass 
operation was ruled out because of the prior double mam- 
mary artery bypass grafts and the belief that, in the event of 
total occlusion of the obtuse marginal graft, only a moderate 
quantity of myocardium would be lost. Because of disabling 
symptoms, the patient was referred for placement of endo- 
vascular stents in the obtuse marginal graft and the graft to 
the diagonal branch. The procedure was performed in April 
1987 (by U. Sigwart, MD) and the patient was asymptomatic 
for 7 months, when angina recurred and angiography re- 
vealed significant restenosis in the midportion of the stent. 
Balloon angioplasty of the lesion within the stent was 
initially successful and the patient had no symptoms for 4 
months, when angina recurred with restenosis in the proxi- 
mal portion of the stent. He was referred for percutaneous 
coronary atherectomy, (performed by J. B. Simpson, MD), 
which was initially successful and reduced a 90% stenosis to 
10%. The vein graft to the diagonal branch, which had the 
second stent in place, was patent with diffuse atherosclerotic 
changes. 
The patient remained asymptomatic until July 1988, when 
his symptoms recurred and he was again referred for percu- 
taneous atherectomy. Angiography revealed that the vein 
graft to the diagonal branch had occluded and there was a 
95% lesion in the distal portion of the stent just distal to the 
atherectomized region. A new significant stenosis appeared 
in the distal portion of the graft just proximal to the distal 
anastomosis. Atherectomy performed within the distal stent 
and on the distal lesion was initially successful with no 
residual angiographic stenosis present. A total of 20 speci- 
mens of fibrous and atherosclerotic material were extracted 
from both lesions. The patient was asymptomatic for 4 
months, but in December 1988 he presented with recurrent 
exertional and rest angina. A third coronary bypass opera- 
tion was again ruled out and the patient, out of desperation, 
was referred for percutaneous excimer laser angioplasty. 
Excimer laser angioplasty. Angiography revealed a 60% 
stenosis of the vein graft to the diagonal branch along with 
first third of the stent in the region of the first percutaneous 
atherectomy. In the distal portion of the stent, a 90% 
stenosis at the site of the second atherectomy was evident. 
In the distal portion of the graft in the previously atherecto- 
mized area, a 60% restenotic lesion was seen (Fig. 3A). 
Excimer laser angioplasty was performed through the right 
femoral artery and an 8F JR4 guide catheter with equipment 
and technique identical to that described in Case 1 was used. 
The 12 x 200 km excimer catheter was calibrated to emit 35 
mJ/mm* per pulse. A 0.018 in. (0.05 cm) guide wire was 
advanced across the lesion and into the native obtuse 
marginal branch without difficulty. Excimer angioplasty was 
performed in the proximal stent, in the distal margin of the 
stent and on the lesion in the distal graft. A total of 1,956 
excimer pulses were applied in nine passes during the 
procedure. Angiography obtained after excimer angioplasty 
revealed that the first lesion in the proximal stent was 
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reduced from 60% to 40%. The lesion at the distal margin of 
the stent was reduced from 90% to no angiographic stenosis, 
and the lesion in the distal portion of the graft was reduced 
from 60% to 20% (Fig. 3B). In an attempt to reduce the 
stenosis at the proximal portion of the stent only, balloon 
angioplasty with a 3.0 mm diameter balloon (Advanced 
Cardiovascular Systems, Inc.) was performed for a total of 
four inflations. No further angiographic improvement over 
that achieved with laser alone could be realized. No balloon 
angioplasty was performed to the second and third lesions 
that had received laser angioplasty. The patient tolerated the 
procedure well. The sheaths were secured and the patient 
was transferred to the intensive care unit where he received 
heparin for 24 h. He was discharged the following day. 
Follow-up. The patient was maintained on aspirin, dil- 
tiazem and propranolol therapy. He was asymptomatic for 5 
weeks, when recurrent angina developed exactly as before 
the laser procedure. His medical therapy was augmented and 
he remained symptomatic (Canadian Cardiovascular Society 
functional class III). Because no further interventions ap- 
pear feasible at this time. he has not undergone repeat 
angiographic study to document restenosis. 
Discussion 
These two cases represent. to our knowledge, the first 
report of percutaneous excimer laser angioplasty applied to 
the coronary circulation. They are presented only to dem- 
onstrate feasibility of the procedure. It is the intent of this 
ongoing study to define the initial efficacy and safety and 
long-term results of excimer angioplasty. Both patients 
suffered from multiple restenosis of vein graft lesions after 
intervention. In Case 1, treatment of one lesion resulted in 
reduction of stenosis from 99% to 30% by laser angioplasty 
alone and in minimal further improvement after balloon 
angioplasty. The patient has remained clinically free from 
restenosis to 8 months. In Case 2, three lesions were treated. 
The first lesion at the origin of the stent was reduced from 
60% to 40% with laser angioplasty and did not improve 
further after balloon dilation. The second lesion was reduced 
from 90% to no significant stenosis and the third lesion from 
60% to 20% stenosis with laser angioplasty alone. This 
patient developed clinical restenosis at 5 weeks. Of interest, 
the post-laser luminal diameter after multiple passes with the 
1.6 mm diameter catheter yielded residual stenosis less than 
would be expected on the basis of catheter dimension alone. 
The mechanism responsible for this observation is unknown. 
Conclusions. These cases demonstrate the feasibility of 
percutaneous coronary excimer laser angioplasty with the 
use of standard cardiac catheterization techniques and 
unique fiber-optic delivery catheters. Further study is re- 
quired to determine the clinical role and potential benefit of 
this procedure relative to established and other investiga- 
tional therapies. 
Addendum 
At the March 1989 Annual Scientific Sessions of the 
American College of Cardiology (I I), results in the first 15 
patients who underwent percutaneous coronary excimer 
laser angioplasty were presented. These included nine pa- 
tients whose procedure was performed at Cedars-Sinai Med- 
ical Center and six whose procedure was performed at South 
Miami Hospital, Miami, Florida. The patients consisted of 
13 men and 2 women. Their mean age was 60.3 years (range 
38 to 85). Six vessels were totally occluded (four right 
coronary arteries, two left circumflex arteries). Thirteen 
stenotic lesions in nine vessels were also treated (two right 
coronary arteries, three left anterior descending arteries, 
four vein grafts). Eight patients were in Canadian Cardio- 
vascular Society functional class II, one patient was in class 
III and six patients were in class IV. Five patients had 
undergone previous coronary artery bypass surgery and 9 
had undergone previous balloon angioplasty. Success, de- 
fined as >20% reduction in stenosis by laser angioplasty 
alone and final stenosis of ~50%~ was achieved in 11 of 
IS patients and IS of 19 lesions. Success was achieved in 
2 of the first 5 patients and in 9 of the last IO patients in the 
series. 
Failures were caused by inability to reach the lesion with 
the laser catheter (two patients), failure to cross a total 
occlusion with a guide wire (one patient) and coronary 
dissection resulting in acute closure and emergency bypass 
surgery (one patient). There were two clinical complications 
and one patient (just described) had a left anterior descend- 
ing artery closure and required surgery. Another patient had 
transient left anterior descending artery occlusion and de- 
velopment of a non-Q wave myocardial infarction. There 
were no perforations and no deaths. 
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